Table S1. Phage titration results of four-round panning. Figure S1. Synthetic scheme of biotinylated peptide.
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Synthesis of succinylhistamine (HS)
Table S1. Phage titration results of four-round panning. FITC-anti-HER2 affibody (2 μg/mL) and B. scFv-L-Aff (7 μg/mL) and anti-His tag mAb FITC (33 μg/mL). C. anti-HER2 affibody (5 μg/mL) was pre-incubated for HER2 blocking followed by scFv-L-Aff (7 μg/mL) and anti-His tag mAb FITC (33 μg/mL) incubation. The nucleus was counterstained with DAPI. 
HS was synthesized and purified according to the known procedure. 1 Briefly, succinic anhydride (1.76 g, 17.6 mmol) was dissolved in DMF (15mL) under nitrogen. Triethylamine (3 mL) was added to the histamine chloride (1.77 g, 9.52 mmol) in DMF (10 mL), and the histamine was dropwised into the succinic anhydride solution. The reaction mixture was stirred at room temperature. After reaction completion, DMF was removed under vacuum, and cold ethanol was added for precipitation. The obtained white powder dried in vacuo. 1 H NMR (CD 3 OD, 400 MHz): 2.44 (m, 2H), 2.57 (m, 2H), 2.85 (t, 2H, J 6.8 Hz), 3.44 (t, 2H, J 6.8 Hz), 7.08 (d, 1H, J 1.2 Hz), 8.12 (d, 1H, J 1.2 Hz). 13 anti-HER2 affibody FITC (2 μg/mL) and B. scFv-L-Aff (7 μg/mL) and anti-His tag mAb FITC (33 μg/mL). C. anti-HER2 affibody (5 μg/mL) was pre-incubated for HER2 blocking followed by scFv-L-Aff (7 μg/mL) and FITC-anti-His tag mAb (33 μg/mL) incubation. The nucleus was counterstained with DAPI. 
